Skip to main content

Y-Intercept (Hong Kong) Ltd

Source: SEC Form 13F · as of Mar 2026

Y-Intercept (Hong Kong) Ltd holds 66 biotech & pharma companies tracked by BioSniper, totaling $141.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

66

Total value held

$141.2M

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.104,293$14.5M
ADMAADMA BIOLOGICS, INC.1,075,422$9.7M
TEVATeva Pharmaceutical Industries Limited302,995$9.1M
UPBUpstream Bio, Inc.1,000,631$9.0M
ANNXAnnexon, Inc.1,319,913$7.3M
INCYIncyte Corp.47,833$4.5M
BMRNBIOMARIN PHARMACEUTICAL INC78,338$4.4M
CMPXCompass Therapeutics, Inc.828,879$4.4M
ARGXARGENX SE5,884$4.3M
CNTACentessa Pharmaceuticals plc96,367$3.8M
ALNYALNYLAM PHARMACEUTICALS, INC.11,361$3.8M
BIOABioAge Labs, Inc.201,337$3.5M
TVTXTravere Therapeutics, Inc.117,361$3.5M
OGNOrganon & Co.476,488$2.9M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)49,164$2.7M
ARDXARDELYX, INC.450,738$2.7M
MLTXMoonLake Immunotherapeutics127,087$2.4M
RGNXREGENXBIO Inc.275,021$2.3M
SMMTSummit Therapeutics Inc.119,655$2.3M
NKTRNEKTAR THERAPEUTICS26,545$1.9M
QUREuniQure N.V.113,952$1.9M
RCUSArcus Biosciences, Inc.86,192$1.9M
ARVNARVINAS, INC.172,808$1.8M
KROSKeros Therapeutics, Inc.164,483$1.8M
ORKAOruka Therapeutics, Inc.36,912$1.8M
NTLAIntellia Therapeutics, Inc.141,081$1.8M
SLNOSOLENO THERAPEUTICS INC47,731$1.6M
DNLIDenali Therapeutics Inc.78,007$1.5M
LENZLENZ Therapeutics, Inc.158,715$1.5M
CLDXCelldex Therapeutics, Inc.45,192$1.4M
ORICOric Pharmaceuticals, Inc.111,992$1.4M
BHVNBiohaven Ltd.161,876$1.4M
CGEMCullinan Therapeutics, Inc.95,417$1.4M
OLMAOlema Pharmaceuticals, Inc.90,375$1.3M
COGTCogent Biosciences, Inc.34,759$1.3M
BEAMBeam Therapeutics Inc.53,164$1.3M
ANABANAPTYSBIO, INC22,701$1.3M
GMABGenmab A/S44,668$1.2M
FLGTFulgent Genetics Inc.67,697$1.1M
IMCRImmunocore Holdings plc34,927$1.1M
SUPNSUPERNUS PHARMACEUTICALS, INC.20,236$1.0M
PRTAPROTHENA CORP PUBLIC LTD CO100,805$980K
XERSXeris Biopharma Holdings, Inc.161,793$938K
NRIXNurix Therapeutics, Inc.55,138$855K
MRNAModerna, Inc.16,510$839K
CTMXCytomX Therapeutics, Inc.167,514$787K
IMTXImmatics N.V.75,427$742K
ANIPANI PHARMACEUTICALS INC9,423$725K
KALVKalVista Pharmaceuticals, Inc.33,776$680K
MAZEMaze Therapeutics, Inc.21,728$649K
ACADACADIA PHARMACEUTICALS INC25,664$571K
AGIOAGIOS PHARMACEUTICALS, INC.13,866$469K
OCULOCULAR THERAPEUTIX, INC54,703$463K
KODKodiak Sciences Inc.10,006$381K
JBIOJade Biosciences, Inc.25,131$353K
APLSApellis Pharmaceuticals, Inc.8,536$343K
SNYSanofi6,492$313K
TGTXTG THERAPEUTICS, INC.9,165$304K
CMPSCOMPASS Pathways plc44,978$249K
FDMT4D Molecular Therapeutics, Inc.25,420$237K
DMRADamora Therapeutics, Inc.7,921$205K
SPRYARS Pharmaceuticals, Inc.15,924$128K
AQSTAquestive Therapeutics, Inc.26,992$112K
RZLTRezolute, Inc.29,554$90K
GERNGERON CORP35,863$53K
PGENPRECIGEN, INC.12,582$49K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.